London, UK, March 28, 2019 (GLOBE NEWSWIRE) -- The pre-filled syringes market has become more competitive in recent years as both syringe component suppliers and pharma companies develop product offerings to compete with established device makers. Rapid growth in this market will be due to the increasing burden of chronic disease, the launch of new biological drugs and biosimilars and pharma companies’ need for more complex drug delivery solutions including innovative pen injectors and autoinjectors.
For free sample pages on this report please click on:
https://www.visiongain.com/report/global-pre-filled-syringes-market-forecast-2019-2029/
The lead analyst of the report commented “The market is expected to grow strongly driven by numerous trends in the overall pharmaceutical market, such as more self-administration of medicines, the development of biological drugs and biosimilars, and the increasing burden of chronic diseases such as diabetes and high cholesterol.
Innovation, suitability for use with viscous and higher-volume drugs and designing products with usability in mind will help manufacturers in this market to differentiate their products and gain market share in an increasingly competitive environment.”
If you are interested in a more detailed overview of this report, please send an e-mail to sara.peerun@visiongain.com or call her on +44 20 7459 9987.
Leading companies featured in the report include BD, Gerresheimer, Schott, SHL Group, Ypsomed and others.
Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to sara.peerun@visiongain.com or call her on +44 20 7459 9987.